By Denny Jacob
Organon shares tumbled 18% in premarket trading after the company cut its dividend and issued weaker quarterly results compared with the prior year.
Shares were trading around $10.60. The stock was down 13% on the year as of Wednesday's close.
The Jersey City, N.J., pharmaceutical company cut its quarterly dividend to 2 cents a share, down from the prior 28 cents a share. Chief Executive Kevin Ali said the company reset its capital-allocation priorities to accelerate its progress toward deleveraging.
Organon logged net income of $87 million on revenue of $1.51 billion in the first quarter, down from $201 million in net income on $1.62 billion in revenue in the prior-year period.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
May 01, 2025 09:09 ET (13:09 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。